HPMA-based polymer conjugates with drug combination
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
19491032
DOI
10.1016/j.ejps.2009.03.011
PII: S0928-0987(09)00111-0
Knihovny.cz E-resources
- MeSH
- Antibiotics, Antineoplastic administration & dosage chemistry MeSH
- Doxorubicin administration & dosage chemistry MeSH
- Drug Combinations MeSH
- Carboxylesterase chemistry MeSH
- Magnetic Resonance Spectroscopy MeSH
- Methacrylates chemical synthesis chemistry MeSH
- Polymers MeSH
- Excipients MeSH
- Spectrophotometry, Ultraviolet MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antibiotics, Antineoplastic MeSH
- Doxorubicin MeSH
- Drug Combinations MeSH
- hydroxypropyl methacrylate MeSH Browser
- Carboxylesterase MeSH
- Methacrylates MeSH
- Polymers MeSH
- Excipients MeSH
Synthesis and physico-chemical behavior of new polymer-drug conjugates intended for the treatment of cancer were investigated. In the polymer conjugate with the expected dual therapeutic activity, two drugs, a cytostatic agent doxorubicin (DOX) and anti-inflammatory drug dexamethason (DEX) were covalently attached to the same polymer backbone via hydrolytically labile pH-sensitive hydrazone bonds. The precursor, a copolymer of N-(2-hydroxypropyl)methacrylamide (HPMA) bearing hydrazide groups randomly distributed along the polymer chain, was conjugated with DOX (through its C13 keto group) or with a keto ester (DEX). Two derivatives of DEX, 4-oxopentanoate and 4-(2-oxopropyl)benzoate esters, were synthesized and employed for conjugation reaction. As a control, also a few polymer conjugates containing only a single drug (DOX or DEX) attached to the polymer carrier were synthesized. Physico-chemical properties of the polymer conjugates strongly depend on the attached drug, spacer structure and the drug content. Polymer-drug conjugates incubated in buffers modeling intracellular environment released the drug (DOX) or a drug derivatives (DEX) at the rate significantly exceeding the release rate observed under conditions mimicking situation in the blood stream. Incubation of the DEX conjugates in a buffer containing carboxyesterase resulted in complete ester hydrolysis thus demonstrating susceptibility of the system to release free active drug in the two-step release profile.
References provided by Crossref.org
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery